U.S. Medical Equipment Stock News

NasdaqGS:HON
NasdaqGS:HONIndustrials

Will Honeywell’s (HON) NHL Arena Deal Redefine Its Automation and Smart-Building Leadership Narrative?

Earlier this month, Honeywell and the National Hockey League announced a multi-year global partnership making Honeywell the Official Building Automation and Energy Management Partner of the NHL, focused on modernizing arenas, practice facilities, and community rinks across North America with its AI-enabled building technologies. The collaboration highlights how Honeywell’s building automation and energy management platforms, such as Honeywell Forge, may become embedded in high-profile sports...
NYSE:HIMS
NYSE:HIMSHealthcare

Hims Benefits Expansion Tests Holistic Wellness Strategy And Valuation Gap

Hims & Hers Health (NYSE:HIMS) expanded its Hims & Hers Benefits program through partnerships with eight new organizations. The new partnerships broaden access to nutrition, fitness, women's health, and metabolic monitoring services for subscribers. The company is passing these negotiated benefits to subscribers at no profit, focusing on holistic health support. Hims & Hers Health, which started with direct to consumer prescription services across areas like hair loss, mental health, and...
NYSE:MOD
NYSE:MODBuilding

Assessing Modine Manufacturing (MOD) Valuation After Major US$4b Data Center Cooling Agreement

Modine Manufacturing (MOD) is back on investor radar after signing a long term capacity agreement to supply more than US$4b of Airedale data center cooling products through 2029, alongside record quarterly and annual results. See our latest analysis for Modine Manufacturing. Those headlines around record results and the multi year data center deal have gone hand in hand with strong momentum, with the share price delivering a 92.24% year to date return and a very large 5 year total shareholder...
NYSE:SYK
NYSE:SYKMedical Equipment

Does Stryker's (SYK) New Pangea Trauma System in Europe Reveal a Deeper Design Advantage?

In May 2026, Stryker launched its Pangea Plating System in Europe, expanding access to a globally co-designed trauma plating platform for treating diverse fracture patterns across upper and lower extremities. The system’s use of global anatomical data and variable-angle plating highlights how Stryker is tailoring implants to fit a wider range of patients and surgical preferences. Next, we’ll examine how this European Pangea launch, alongside recent operational challenges, may influence...
NasdaqGS:ULCC
NasdaqGS:ULCCAirlines

Frontier Group Holdings (ULCC) Is Up 18.6% After Deferring Jet Deliveries And Tightening Fleet Strategy

Earlier this week, Frontier Group Holdings reported a strong first-quarter revenue outlook with around 15% growth in Revenue per Available Seat Mile and outlined plans to defer some aircraft deliveries and terminate select leases to better manage capital spending and fleet use amid uncertain economic conditions. The combination of improving fuel cost pressures after easing geopolitical tensions and Frontier’s efforts to tighten capacity and capital outlays highlights how both external and...
NYSE:NEE
NYSE:NEEElectric Utilities

A Look At NextEra Energy (NEE) Valuation After Recent Share Price Pullback

NextEra Energy stock in focus NextEra Energy (NEE) is back on watch for investors after a recent pullback, with the stock down about 10% over the past month and roughly 7% over the past 3 months. See our latest analysis for NextEra Energy. While the recent pullback has cooled short term momentum, NextEra Energy’s year to date share price return of 7.81% and 1 year total shareholder return of 30.23% point to a stock that has rewarded patient holders, even as sentiment has turned more cautious...
NYSE:F
NYSE:FAuto

Ford (F) Is Up 21.8% After Reshaping Battery Assets And Securing Major EDF Storage Deal

In May 2026, Ford Motor reshaped its battery and financing structure by exiting the BlueOval SK joint venture, assuming a US$3.81 billion Department of Energy loan at 4.814% for its Kentucky battery plant, and regaining direct control of those assets. At the same time, Ford’s new Ford Energy unit secured a five-year framework to supply up to 20 GWh of battery storage systems to EDF Power Solutions North America, signaling a push to repurpose its battery capacity into grid-scale energy and...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Assessing Vertex Pharmaceuticals (VRTX) Valuation After Health Canada Review Progress For Suzetrigine

Vertex Pharmaceuticals (VRTX) is back in focus after Health Canada agreed to review suzetrigine, a first in class non-opioid oral treatment for moderate to severe acute pain in adults. See our latest analysis for Vertex Pharmaceuticals. The Health Canada review news comes as Vertex shares trade at US$447.97, with a 1 day share price return of 2.46% and a 30 day share price return of 4.15%. However, the 90 day share price return is down 9.83%. Against that backdrop, the 5 year total...
NYSE:GS
NYSE:GSCapital Markets

How Goldman’s Crypto Pivot Toward Value-Capture Protocols Will Impact Goldman Sachs Group (GS) Investors

In late May 2026, Goldman Sachs Group reshaped its digital asset exposure by fully exiting XRP and Solana ETFs, sharply cutting its Ethereum ETF holdings, and opening a new position in a digital asset treasury company linked to the Hyperliquid decentralized derivatives exchange. This shift, alongside the bank’s ongoing AI-focused market commentary and competitive 4% APY Marcus CDs, highlights how Goldman is repositioning around where it sees more durable value capture in financial technology...
NasdaqGS:LI
NasdaqGS:LIAuto

Li Auto (NasdaqGS:LI) Returns To Losses In Q1 2026 Testing Bullish Profitability Narratives

Li Auto (NasdaqGS:LI) opened 2026 with Q1 revenue of ¥22.98b and a reported loss of ¥2.29b, or EPS of ¥2.26, setting a cautious tone around profitability. The company has seen quarterly revenue move from ¥44.27b in Q4 2024 to ¥22.98b in Q1 2026, while EPS has swung from ¥3.52 to a loss of ¥2.26, putting the focus squarely on how well costs are being managed against that revenue base. With investors already watching forecasts for earnings growth and a shift toward profitability, this quarter's...
NYSE:BLK
NYSE:BLKCapital Markets

BlackRock’s Record Bitcoin ETF Block Trade Highlights Shifting Institutional Positioning

BlackRock executed a record $1.29b dark pool trade in its bitcoin ETF, marking the largest transaction of its kind to date. The trade highlights institutional use of BlackRock's crypto ETF platform during a period of heightened crypto ETF activity. This comes as the crypto sector faces regulatory scrutiny and recent ETF outflows across parts of the market. For investors tracking BlackRock (NYSE:BLK), the record $1.29b dark pool transaction lands at a time when the stock trades around...
NasdaqCM:SHIP
NasdaqCM:SHIPShipping

Seanergy Maritime Holdings (SHIP) Q1 Net Margin Strengthens Bullish Narratives On Earnings Power

Seanergy Maritime Holdings (NasdaqCM:SHIP) opened 2026 with Q1 revenue of US$42.9 million and basic EPS of US$0.46, setting a clear marker for how the dry bulk shipper is currently earning its freight. The company has seen quarterly revenue move from US$24.2 million and a loss of US$0.34 per share in Q1 2025 to US$42.9 million and EPS of US$0.46 in Q1 2026. Trailing 12 month EPS stands at US$1.81 on revenue of US$176.7 million, giving investors a results set where margins and profit trends...
NasdaqGS:BRZE
NasdaqGS:BRZESoftware

Braze (BRZE) Q1 Loss Of US$26.6 Million Tests Bullish Margin Narratives

Braze (BRZE) just posted its Q1 2027 numbers, reporting revenue of US$211.0 million and a basic EPS loss of US$0.24, with net income excluding extra items showing a loss of US$26.6 million. The company has seen quarterly revenue move from US$162.1 million in Q1 2026 through US$205.2 million in Q4 2026 to US$211.0 million in Q1 2027. Over the same stretch, basic EPS went from a loss of US$0.34 to a loss of US$0.29 and then a loss of US$0.24, which may lead investors to focus on how efficiently...
NYSE:BSX
NYSE:BSXMedical Equipment

Assessing Boston Scientific (BSX) Valuation After Strong SEISMIQ 4CE Trial Results

Boston Scientific (BSX) is back in focus after reporting strong pivotal trial data for its SEISMIQ 4CE coronary intravascular lithotripsy catheter, which met key safety and effectiveness goals in patients with severely calcified coronary artery disease. See our latest analysis for Boston Scientific. The strong SEISMIQ 4CE trial update comes against a weak recent trading backdrop, with the share price down 16% over 30 days and the 1-year total shareholder return down 53%, although the 5-year...
NYSE:PCG
NYSE:PCGElectric Utilities

PG&E Grant Program Highlights ESG Focus As Shares Trade Below Targets

PG&E Foundation has launched the Nature Positive Innovation Grant program to fund environmental stewardship projects. The program focuses on supporting community based initiatives within PG&E's service area that aim to restore and protect natural habitats. This new grant effort adds another ESG focused element to PG&E's community engagement activities. For investors watching NYSE:PCG, this new grant program arrives as the stock trades around $16.29 and has recorded a gain of 58.4% over the...
NasdaqCM:GRRR
NasdaqCM:GRRRSoftware

Gorilla Technology Group (GRRR) Net Loss Deepens Again And Tests Profitability Narratives

Gorilla Technology Group (NasdaqCM:GRRR) opened 2026 with Q1 revenue of about US$28.2 million and a basic EPS loss of US$1.42, alongside a net income loss of roughly US$37.0 million that keeps margins under pressure. The company has seen revenue move from about US$18.3 million in Q1 2025 and US$33.9 million in Q4 2024 to the latest US$28.2 million figure, while quarterly basic EPS has ranged from a loss of US$0.23 in Q1 2025 to a deeper loss of US$4.46 in Q4 2024 before landing at a loss of...
NasdaqGS:ETOR
NasdaqGS:ETORCapital Markets

Bernie Moreno Share Sale Puts eToro Group Valuation And Sentiment In Focus

Senator Bernie Moreno has disclosed a significant sale of eToro Group shares, as required under congressional stock transaction rules. The transaction involves NasdaqGS:ETOR and has been formally reported under legislative disclosure requirements. The sale draws attention to transparency standards for public officials trading in publicly listed companies. For investors tracking NasdaqGS:ETOR, the disclosure comes as eToro Group trades at a share price of $39.94. The stock is up 0.8% over...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Johnson And Johnson MedTech Moves And What They Could Mean For Investors

Johnson & Johnson subsidiaries are integrating Gemtrack radiofrequency tracking technology from MinMaxMedical into DePuy Synthes orthopedic products. The company has brought CMS Laser into its medical device production lines for laser manufacturing capabilities. Johnson & Johnson recently closed its acquisition of Atraverse Medical, adding to its cardiac electrophysiology tools. Johnson & Johnson (NYSE:JNJ) is adding these MedTech moves on top of a share price of $230.8 and a 1 year return...
NasdaqGS:AAL
NasdaqGS:AALAirlines

Why American Airlines Group (AAL) Is Up 7.8% After Starlink Wi-Fi Deal And Competitive Tailwinds

In recent weeks, American Airlines Group announced plans to install SpaceX’s Starlink satellite internet on more than 500 Airbus narrowbody aircraft from early 2027, while benefiting from strong travel demand, easing fuel costs, and the market exit of ultra-low-cost competitor Spirit Airlines. Together, these shifts suggest American is trying to reposition itself as a higher-quality network carrier with improved pricing power and a sharper focus on the onboard experience. Next, we’ll explore...
NYSE:P
NYSE:PTech

Is It Too Late To Consider Everpure (P) After Its Strong Multi Year Rally?

Wondering whether Everpure at US$73.04 still offers value, or if the best gains are already behind it? This article walks through what the current price might be saying about the stock. The share price has been volatile recently, with a decline of 7.5% over the last week sitting against gains of 3.0% over the past month, 5.8% year to date, and 36.2% over the last year, on top of a very large 3 year return and around a 3x move over 5 years. Recent coverage has focused on how Everpure fits...
NYSE:UHAL
NYSE:UHALTransportation

U Haul Holding UHAL Margin Squeeze To 1.4% Tests Bullish Earnings Narratives

U-Haul Holding (UHAL) has wrapped up FY 2026 with a mixed set of numbers, as fourth quarter revenue came in at US$1.3 billion and the company reported a loss of US$127.8 million, or basic EPS of US$0.65. The trailing twelve months show total revenue of US$6.0 billion and net income of US$83.1 million, equal to basic EPS of US$0.42. Over the last six reported quarters, revenue has ranged from US$1.2 billion to US$1.7 billion and quarterly basic EPS has swung between a loss of US$0.65 and a...
NasdaqGS:WTW
NasdaqGS:WTWInsurance

Assessing Willis Towers Watson (WTW) Valuation After A Sharp Share Price Pullback

What recent performance signals for Willis Towers Watson stock Willis Towers Watson (WTW) has seen its stock retreat recently, with the price down 13% over the past month and 17% over the past 3 months, prompting fresh attention from investors. See our latest analysis for Willis Towers Watson. The recent pullback fits into a wider trend, with the share price down 22.76% year to date and the 1-year total shareholder return declining 19.12%, even though the 3-year total shareholder return is...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

A Look At Sirius XM Holdings (SIRI) Valuation After Its Recent Share Price Momentum

Recent performance and what is driving interest in Sirius XM Holdings (SIRI) Sirius XM Holdings (SIRI) has drawn fresh attention after a strong share price run, with the stock up about 14% over the past month and roughly 36% in the past 3 months. See our latest analysis for Sirius XM Holdings. That recent momentum builds on a stronger year to date, with a 45.64% share price return since January and a 39.96% total shareholder return over the past year. However, longer term total shareholder...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

How Investors May Respond To Alnylam Pharmaceuticals (ALNY) Adding Scientific Depth Amid RNAi Pipeline Scrutiny

Alnylam Pharmaceuticals recently expanded its Board of Directors from ten to eleven members and appointed Benjamin F. Cravatt, Ph.D., as a Class III director through 2028, also adding him to its Science and Technology Committee. His appointment brings additional scientific expertise to the boardroom at a time when Alnylam’s RNA interference pipeline and ATTR-CM program are under heightened investor scrutiny following new clinical data and fresh analyst coverage. Next, we’ll examine how...